Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + amodiaquine and artemether + lumefantrine for uncomplicated falciparum malaria in children in Lambarene, Gabon
ACTRN12616001600437Phase 4Completed
- Sponsor
- Ministry of Health and Population Gabon
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, amodiaquine, artemether and lumefantrine in malaria and Falciparum malaria (PF) (2 arms), sponsored by Ministry of Health and Population Gabon. Primary endpoints: Percentage of treatment failures, Adequate clinical and parasitological response and 1 more. Started Nov 2017; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12616001600437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001600437.